Phosphinecarboxylic acid, ((2,3-dihydro-1H-inden-5-yl)oxy)hydroxy-, methyl ester, oxide | 72304-97-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 茚满类
• 英文名称: Phosphinecarboxylic acid, ((2,3-dihydro-1H-inden-5-yl)oxy)hydroxy-, methyl ester, oxide
• 英文别名: 2,3-dihydro-1H-inden-5-yloxy(methoxycarbonyl)phosphinic acid
• CAS: 72304-97-3
• 化学式: C₁₁H₁₃O₅P
• 分子量: 256.19
• InChiKey: QPMGKEAXZZUEFI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  72.8
• 氢给体数：
  1
• 氢受体数：
  5

文献信息

• Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections
  申请人：Astra Läkemedel Aktiebolag

  公开号：EP0003007A2

  公开（公告）日：1979-07-11

  1. A pharmaceutical preparation containing as active ingredient a compound of the formula wherein R, and R2 are the same or different, and each is selected from the group consisting of hydrogen, alkyl groups containing 1-6 carbon atoms; cycloalkyl groups containing 3-6 carbon atoms; cycloalkyl-alkyl groups containing 4-6 carbon atoms: 1-adamantyl; 2-adamantyl, benzyl; and phenyl groups of the formula wherein R. and R5 are the same or different, and each is selected from the group consisting of hydrogen, halogen, alkyl having 1, 2, or 3 carbon atoms, alkoxy having 1, 2, or 3 carbon atoms, alkoxycarbonyl having 2-7 carbon atoms and alkylcarbonyl groups having 2-7 carbon atoms; or R. and R5 together form a straight saturated alkylene chain having 3 or 4 carbon atoms and being bound to adjacent positions, i.e. 2,3- or 3,4- in the phenyl ring; and R3 is selected from the group consisting of hydrogen, alkyl groups containing 1-8 carbon atoms; cycloalkyl groups containing 3-8 carbon atoms; cycloalkyl-alkyl groups containing 4-8 carbon atoms; 1-adamantyl; 2- adamantyl; benzyl; and phenyl groups of the formula wherein R4 and Rs have the meaning given above; provided that at least one of the groups R,, R2 and R3 is alkyl, cycloalkyl, or cycloalkyl-alkyl as defined above, or 1-adamantyl, 2-adamantyl, or benzyl; and provided that when R3 is H, then one of R, and R2 is alkyl, cycloalkyl, or cycloalkyl-alkyl as defined above, or 1-adamantyl, 2-adamantyl, or benzyl and the other of R, and R2 is H; or a physiologically acceptable salt or an optical isomer thereof; novel compounds within formula I, methods for their preparation and their medicinal use.

  1.一种药物制剂，其活性成分为如下式中的化合物 其中 R 和 R2 相同或不同，且各自选自由下列组成的组氢、含 1-6 个碳原子的烷基、含 3-6 个碳原子的环烷基、含 4-6 个碳原子的环烷基-烷基：1-金刚烷基；2-金刚烷基；苄基；以及式中的苯基。 其中 R.和 R5 相同或不同，且各自选自由氢、卤素、具有 1、2 或 3 个碳原子的烷基、具有 1、2 或 3 个碳原子的烷氧基、具有 2-7 个碳原子的烷氧羰基和具有 2-7 个碳原子的烷基羰基组成的组；或 R.和 R5 共同形成具有 3 或 4 个碳原子的直链饱和亚烷基，并结合到苯基环的相邻位置，即 2,3- 或 3,4- 位； R3 选自氢、含 1-8 个碳原子的烷基、含 3-8 个碳原子的环烷基、含 4-8 个碳原子的环烷基-烷基、1-金刚烷基、2-金刚烷基、苄基和式中的苯基所组成的组。 其中 R4 和 Rs 具有上述含义；条件是基团 R、R2 和 R3 中至少有一个是如上定义的烷基、环烷基或环烷基-烷基，或 1-金刚烷基、2-金刚烷基或苄基；且当 R3 为 H 时，则 R 和 R2 中的一个为如上定义的烷基、环烷基或环烷基-烷基，或 1-金刚烷基、2-金刚烷基或苄基，而 R 和 R2 中的另一个为 H；或其生理上可接受的盐或光学异构体；式 I 内的新型化合物、其制备方法及其药用用途。
• Aromatic derivatives of phosphonoformic acid, processes for their preparation, pharmaceutical compositions containing them and their use for combating virus infections
  申请人：Astra Läkemedel Aktiebolag

  公开号：EP0003275A1

  公开（公告）日：1979-08-08

  A compound of the formula wherein R,, R2 and R3 are the same or different, and each is selected from the group consisting of hydrogen and phenyl groups of the formula wherein R4 and R5 are the same or different and each is. selected from the group consisting of hydrogen, halogen, alkyl having 1; 2, or 3 carbon atoms, alkoxy having 7,2. or 3 carbon atoms, alkoxycarbonyl having 2-7 carbon atoms; and alkylcarbonyl groups having 2-7 carbon atoms; or R4 and R5 together form a straight saturated alkylene chain having 3 or 4 carbon atoms and being bound to adjacent positions, i.e. 2,3- or 3,4- in the phenyl ring; provided that one of R1 and R2 is a phenyl group of the formula II when R3 is H; and physiologically acceptable salts and optical isomers thereof; methods for preparation of the compounds, pharmaceutical compositions containing them, and their medicinal use.

  式中的化合物 其中 R、R2 和 R3 相同或不同，且各自选自由氢和式中的苯基组成的组 其中 R4 和 R5 相同或不同，且各自选自由氢、卤素、具有 1；2 或 3 个碳原子的烷基、具有 7、2. 或 3 个碳原子的烷氧基、具有 2-7 个碳原子的烷氧羰基；以及具有 2-7 个碳原子的烷基羰基组成的组；或 R4 和 R5 共同形成具有 3 或 4 个碳原子的直饱和亚烷基链，并与相邻位置结合，即即苯基环中的2,3-或3,4-；条件是当R3为H时，R1和R2中的一个是式II的苯基；以及它们的生理上可接受的盐和光学异构体；化合物的制备方法、含有它们的药物组合物及其药用用途。
• US4372894A
  申请人：——

  公开号：US4372894A

  公开（公告）日：1983-02-08
• US4386081A
  申请人：——

  公开号：US4386081A

  公开（公告）日：1983-05-31
• US4536400A
  申请人：——

  公开号：US4536400A

  公开（公告）日：1985-08-20